|
|
№7 (приложение) / 2021
|
|
|
№7 (приложение) / 2021
|
|
Pereverzev A.P., Ostroumova O.D.
Drug-induced hyperuricemia/gout. Part 2: certain medicines, the use of which is associated with an increased risk of developing of these diseases
|
№7 / 2021
|
|
Kostina N.E., Starodubtseva I.A., Sharapova Yu.A., Malyavin A.G.
Interstitial lung diseases, progressive phenotype: urgent problems of early diagnosis and early initiation of antifibrotic therapy
|
№7 / 2021
|
|
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
|
№7 / 2021
|
|
Zueva I.B., Kim Yu.V., Suslova M.Yu.
How to optimize the management of patients with post-infectious asthenia who have undergone COVID-19 at the outpatient stage?
|
№6 / 2021
|
|
Expert board resolution: possibilities of ethiotropic therapy for respiratory infections caused by RNA viruses
|
№5 / 2021
|
|
Erofeeva S.B.
Features of management of patients with acute respiratory viral infections
|
№5 / 2021
|
|
Trukhan D.I., Filimonov S.N.
Treatment of arterial hypertension I–II stages in patients with risk of cardiovascular complications above moderate in real clinical practice: possibilities of indapamide in a combined therapy
|
№5 / 2021
|
|
Kovalenko E.A., Osinovskaya N.A., Bogolepova A.N.
Dementia: diagnostic aspects, prevention and treatment
|
№5 / 2021
|
|
Kokorin V.A., Boeva O.I.
Treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: is there a light at the end of the tunnel?
|
№5 / 2021
|
|
Kamchatnov P.R., Chugunov A.V., Ashalmagomedova Z.A., Shemshedinova A.M.
Modern principles of management of a patient with acute dorsalgia
|
№5 / 2021
|
Русский
